{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:14:18Z","timestamp":1791396858206,"version":"4.3.3"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["0315226A"],"award-info":[{"award-number":["0315226A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["0315226B"],"award-info":[{"award-number":["0315226B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["0315226D"],"award-info":[{"award-number":["0315226D"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ejpb.2012.11.008","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T02:16:13Z","timestamp":1354155373000},"page":"374-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Esterase activity in excised and reconstructed human skin \u2013 Biotransformation of prednicarbate and the model dye fluorescein diacetate"],"prefix":"10.1016","volume":"84","author":[{"given":"Franzisca Marie","family":"B\u00e4tz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Klipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Christian","family":"Korting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Henkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Landsiedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Luch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"von Fritschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Weindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Sch\u00e4fer-Korting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2012.11.008_b0005","unstructured":"H. Kandarova, Evaluation and Validation of Reconstructed Human Skin Models as Alternatives to Animal Tests in Regulatory Toxicology, PhD thesis, Department of Biology, Chemistry and Pharmacy, Freie Universit\u00e4t Berlin, Berlin, 2006, pp. 167."},{"key":"10.1016\/j.ejpb.2012.11.008_b0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejpb.2005.03.004","article-title":"SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport, the human epidermis models EpiSkin","volume":"60","author":"Netzlaff","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2012.11.008_b0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.tiv.2005.11.008","article-title":"Assessment of the human epidermis model SkinEthic RHE for in vitro skin corrosion testing of chemicals according to new OECD TG 431","volume":"20","author":"Kandarova","year":"2006","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ejpb.2012.11.008_b0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2131\/jts.35.411","article-title":"Assessment of the human epidermal model LabCyte EPI-MODEL for in vitro skin corrosion testing according to the OECD test guideline 431","volume":"35","author":"Katoh","year":"2010","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.ejpb.2012.11.008_b0025","unstructured":"OECD, Test Guideline 431: In Vitro Skin Corrosion: Human Skin Model Test, OECD Guidelines for the Testing of Chemicals, Section 4, 2004."},{"key":"10.1016\/j.ejpb.2012.11.008_b0030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/026119290703500608","article-title":"The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals","volume":"35","author":"Eskes","year":"2007","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.ejpb.2012.11.008_b0035","unstructured":"OECD, Test Guideline 439: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method, OECD Guidelines for the Testing of Chemicals, Section 4, 2010."},{"key":"10.1016\/j.ejpb.2012.11.008_b0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/026119290703500614","article-title":"The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test","volume":"35","author":"Spielmann","year":"2007","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.ejpb.2012.11.008_b0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/026119290503300307","article-title":"Assessment of the eye irritating properties of chemicals by applying alternatives to the Draize rabbit eye test: the use of QSARs and in vitro tests for the classification of eye irritation","volume":"33","author":"Gerner","year":"2005","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.ejpb.2012.11.008_b0050","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.tiv.2007.04.012","article-title":"The EpiSkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency","volume":"21","author":"Lelievre","year":"2007","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ejpb.2012.11.008_b0055","unstructured":"OECD, Test Guideline 432: In vitro 3T3 NRU phototoxicity test, OECD Guidelines for the Testing of Chemicals, Section 4, 2004."},{"key":"10.1016\/j.ejpb.2012.11.008_b0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejpb.2006.08.012","article-title":"Permeability of the reconstructed human epidermis model Episkin in comparison to various human skin preparations","volume":"66","author":"Netzlaff","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2012.11.008_b0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/026119290803600207","article-title":"The use of reconstructed human epidermis for skin absorption testing: results of the validation study","volume":"36","author":"Sch\u00e4fer-Korting","year":"2008","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.ejpb.2012.11.008_b0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000265681","article-title":"The Phenion full-thickness skin model for percutaneous absorption testing","volume":"23","author":"Ackermann","year":"2010","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/026119290803600405","article-title":"Reconstructed epidermis and full-thickness skin for absorption testing: influence of the vehicles used on steroid permeation","volume":"36","author":"Sch\u00e4fer-Korting","year":"2008","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.ejpb.2012.11.008_b0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000112959","article-title":"Improvement of the experimental setup for skin absorption screening studies with reconstructed skin EPISKIN","volume":"21","author":"Gregoire","year":"2008","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0085","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ejpb.2007.05.003","article-title":"In vitro skin absorption and drug release \u2013 a comparison of six commercial prednicarbate preparations for topical use","volume":"68","author":"Lombardi Borgia","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2012.11.008_b0090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/1061186021000038364","article-title":"Drug targeting by solid lipid nanoparticles for dermal use","volume":"10","author":"Santos Maia","year":"2002","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ejpb.2012.11.008_b0095","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2174\/138920007782798225","article-title":"Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review","volume":"8","author":"Gibbs","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejpb.2012.11.008_b0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000422363","article-title":"Metabolism of topical drugs within the skin, in particular glucocorticoids","volume":"21","author":"Kubota","year":"1993","journal-title":"Curr. Probl. Dermatol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/10837450902890958","article-title":"Importance of knowledge on drug metabolism for the safe use of drugs in humans","volume":"41","author":"Oesch","year":"2009","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejpb.2012.11.008_b0110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/03602530701690366","article-title":"Drug-metabolizing enzymes in the skin of man, rat, and pig","volume":"39","author":"Oesch","year":"2007","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejpb.2012.11.008_b0115","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.tiv.2010.03.013","article-title":"Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin","volume":"24","author":"Hu","year":"2010","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ejpb.2012.11.008_b0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsbmb.2007.03.036","article-title":"Steroid metabolism and profile of steroidogenic gene expression in Episkin: high similarity with human epidermis","volume":"107","author":"Luu-The","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0125","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1600-0625.2012.01478.x","article-title":"Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: phase II enzymes","volume":"21","author":"G\u00f6tz","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0130","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1600-0625.2012.01486.x","article-title":"Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes Phase I","volume":"21","author":"G\u00f6tz","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0135","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jsbmb.2009.05.011","article-title":"Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models Episkin and full thickness model from Episkin","volume":"116","author":"Luu-The","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000257261","article-title":"Expression and induction of cytochrome P450 isoenzymes in human skin equivalents","volume":"23","author":"Neis","year":"2010","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0145","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/js960408n","article-title":"Effects of skin metabolism on percutaneous penetration of lipophilic drugs","volume":"86","author":"Bando","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2012.11.008_b0150","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jps.2600841215","article-title":"Simultaneous diffusion and metabolism of betamethasone 17-valerate in the living skin equivalent","volume":"84","author":"Kubota","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2012.11.008_b0155","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0272-0590(90)90170-O","article-title":"Metabolism of xenobiotics during percutaneous penetration: role of absorption rate and cutaneous enzyme activity","volume":"15","author":"Storm","year":"1990","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/dmd.108.024794","article-title":"Biotransformation of drugs in human skin","volume":"37","author":"Svensson","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2012.11.008_b0165","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1023\/A:1018946924585","article-title":"Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin","volume":"16","author":"Gysler","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2012.11.008_b0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000029913","article-title":"Cutaneous inflammation and proliferation in vitro: differential effects and mode of action of topical glucocorticoids","volume":"13","author":"Lange","year":"2000","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000084907","article-title":"Glucocorticoids for human skin: new aspects of the mechanism of action","volume":"18","author":"Sch\u00e4fer-Korting","year":"2005","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0180","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/clpt.1993.172","article-title":"Prednicarbate activity and benefit\/risk ratio in relation to other topical glucocorticoids","volume":"54","author":"Sch\u00e4fer-Korting","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2012.11.008_b0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000288164","article-title":"Hydrocortisone aceponate activity and benefit\/risk ratio in relation to reference topical glucocorticoids","volume":"23","author":"Wohlrab","year":"2010","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0190","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1023\/A:1012162708675","article-title":"Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts","volume":"14","author":"Gysler","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2012.11.008_b0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000069754","article-title":"Transcriptional activity of potent glucocorticoids: relevance of glucocorticoid receptor isoforms and drug metabolites","volume":"16","author":"Spika","year":"2003","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0200","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tiv.2005.08.013","article-title":"The impact of skin viability on drug metabolism and permeation \u2013 BSA toxicity on primary keratinocytes","volume":"20","author":"Haberland","year":"2006","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ejpb.2012.11.008_b0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/026119291103900212","article-title":"Evaluation of anti-inflammatory and atrophogenic effects of glucocorticoids on reconstructed human skin","volume":"39","author":"Weindl","year":"2011","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.ejpb.2012.11.008_b0210","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000203368","article-title":"Comparative permeation studies of nondiluted and diluted betamethasone-17-valerate semisolid formulations through isolated human stratum corneum and artificial skin construct","volume":"22","author":"Mitriaikina","year":"2009","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000324053","article-title":"Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids","volume":"24","author":"Schlupp","year":"2011","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0220","first-page":"1813","article-title":"All-trans retinoic acid and extracellular Ca2+ differentially influence extracellular matrix production by human skin in organ culture","volume":"142","author":"Varani","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0225","first-page":"3664","article-title":"Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling","volume":"117","author":"Weindl","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejpb.2012.11.008_b0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/abio.2000.4977","article-title":"Use of the tape stripping technique for directly quantifying esterase activities in human stratum corneum","volume":"290","author":"Beisson","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejpb.2012.11.008_b0235","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nprot.2008.114","article-title":"The fluorometric microculture cytotoxicity assay","volume":"3","author":"Lindhagen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejpb.2012.11.008_b0240","unstructured":"I. Brinkmann, C. M\u00fcller-Goymann, Prednicarbate permeation through artificial skin construct from different formulations and their dilutions, in: Proceedings of the International Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Nuremberg, 2004."},{"key":"10.1016\/j.ejpb.2012.11.008_b0245","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/026119290603400312","article-title":"Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study","volume":"34","author":"Sch\u00e4fer-Korting","year":"2006","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.ejpb.2012.11.008_b0250","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1248\/bpb.30.532","article-title":"Stereoselective characteristics and mechanisms of epidermal carboxylesterase metabolism observed in HaCaT keratinocytes","volume":"30","author":"Zhu","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2012.11.008_b0255","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.toxlet.2007.07.004","article-title":"The distribution of esterases in the skin of the minipig","volume":"173","author":"Jewell","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejpb.2012.11.008_b0260","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1124\/dmd.107.015727","article-title":"Specificity of procaine and ester hydrolysis by human, minipig, and rat skin and liver","volume":"35","author":"Jewell","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2012.11.008_b0265","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1023\/A:1012183914011","article-title":"Prednicarbate versus conventional topical glucocorticoids: pharmacodynamic characterization in vitro","volume":"14","author":"Lange","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2012.11.008_b0270","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ACI.0b013e3283079c64","article-title":"The roles of drug metabolism in the pathogenesis of T-cell-mediated drug hypersensitivity","volume":"8","author":"Lavergne","year":"2008","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0275","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2174\/138920009790711823","article-title":"Metabolomics in drug intolerance","volume":"10","author":"Andreu","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejpb.2012.11.008_b0280","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1465-9921-5-7","article-title":"Significant receptor affinities of metabolites and a degradation product of mometasone furoate","volume":"5","author":"Valotis","year":"2004","journal-title":"Respir Res."},{"key":"10.1016\/j.ejpb.2012.11.008_b0285","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00063030-200013040-00005","article-title":"Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio","volume":"13","author":"Schackert","year":"2000","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejpb.2012.11.008_b0290","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000072930","article-title":"Testosterone metabolism in human skin cells in vitro and its interaction with estradiol and dutasteride","volume":"16","author":"M\u00fcnster","year":"2003","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0295","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000270386","article-title":"Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy","volume":"23","author":"Schoepe","year":"2010","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0300","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.tiv.2007.11.022","article-title":"Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model","volume":"22","author":"Z\u00f6ller","year":"2008","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ejpb.2012.11.008_b0305","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drudis.2010.12.001","article-title":"In vitro models for human skin disease","volume":"16","author":"Semlin","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2012.11.008_b0310","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/17425247.2011.568937","article-title":"Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations","volume":"8","author":"Van Gele","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2012.11.008_b0315","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000093980","article-title":"Topical delivery of retinyl ascorbate co-drug. 5. In vitro degradation studies","volume":"19","author":"Abdulmajed","year":"2006","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0320","unstructured":"OECD, Test Guideline 428: Skin Absorption: In Vitro Method, OECD Guidelines for the Testing of Chemicals, Section 4, 2004."},{"issue":"Suppl 1","key":"10.1016\/j.ejpb.2012.11.008_b0325","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000066682","article-title":"Characterization of reconstructed skin models","volume":"15","author":"Ponec","year":"2002","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0330","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-3659(99)00039-5","article-title":"Simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin after its topical application: the effect of enzyme distribution in skin","volume":"62","author":"Sugibayashi","year":"1999","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2012.11.008_b0335","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1124\/dmd.106.009381","article-title":"Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine","volume":"34","author":"Imai","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2012.11.008_b0340","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/jid.2011.126","article-title":"Full-thickness human skin models for congenital ichthyosis and related keratinization disorders","volume":"131","author":"Eckl","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2012.11.008_b0345","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ajhg.2010.07.005","article-title":"Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease","volume":"87","author":"Oji","year":"2010","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.ejpb.2012.11.008_b0350","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/026119291103900508","article-title":"Hallmarks of atopic skin mimicked in vitro by means of a skin disease model based on FLG knock-down","volume":"39","author":"K\u00fcchler","year":"2011","journal-title":"Altern. Lab. Anim."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641112003748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641112003748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:30:04Z","timestamp":1760545804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641112003748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0939641112003748"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2012.11.008","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esterase activity in excised and reconstructed human skin \u2013 Biotransformation of prednicarbate and the model dye fluorescein diacetate","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2012.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}